Literature DB >> 33046555

4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response.

Somasish Ghosh Dastidar1,2,3, Michael T Pham4,2, Matthew B Mitchell2, Steven G Yeom2, Sarah Jordan2, Angela Chang2, Bryce L Sopher5, Albert R La Spada1,2,6.   

Abstract

Decline of protein quality control in neurons contributes to age-related neurodegenerative disorders caused by misfolded proteins. 4E-BP1 is a key node in the regulation of protein synthesis, as activated 4E-BP1 represses global protein translation. Overexpression of 4E-BP1 mediates the benefits of dietary restriction and can counter metabolic stress, and 4E-BP1 disinhibition on mTORC1 repression may be neuroprotective; however, whether 4E-BP1 overexpression is neuroprotective in mammalian neurons is yet to be fully explored. To address this question, we generated 4E-BP1-overexpressing transgenic mice and confirmed marked reductions in protein translation in 4E-BP1-overexpressing primary neurons. After documenting that 4E-BP1-overexpressing neurons are resistant to proteotoxic stress elicited by brefeldin A treatment, we exposed primary neurons to three different Parkinson's disease (PD)-linked toxins (rotenone, maneb, or paraquat) and documented significant protection in neurons from newborn male and female 4E-BP1-OE transgenic mice. We observed 4E-BP1-dependent upregulation of genes encoding proteins that comprise the mitochondrial unfolded protein response, and noted 4E-BP1 overexpression required activation of the mitochondrial unfolded protein response for neuroprotection against rotenone toxicity. We also tested whether 4E-BP1 could prevent α-synuclein neurotoxicity by treating 4E-BP1-overexpressing primary neurons with α-synuclein preformed fibrils, and we observed marked reductions in α-synuclein aggregation and neurotoxicity, thus validating that 4E-BP1 is a powerful suppressor of PD-linked pathogenic insults. Our results indicate that increasing 4E-BP1 expression or enhancing 4E-BP1 activation can robustly induce the mitochondrial unfolded protein response and thus could be an appealing strategy for treating a variety of neurodegenerative diseases, including especially PD.SIGNIFICANCE STATEMENT In neurodegenerative disease, misfolded proteins accumulate and overwhelm normal systems of homeostasis and quality control. One mechanism for improving protein quality control is to reduce protein translation. Here we investigated whether neuronal overexpression of 4E-BP1, a key repressor of protein translation, can protect against misfolded protein stress and toxicities linked to Parkinson's disease, and found that 4E-BP1 overexpression prevented cell death in neurons treated with brefeldin A, rotenone, maneb, paraquat, or preformed fibrils of α-synuclein. When we sought the basis for 4E-BP1 neuroprotection, we discovered that 4E-BP1 activation promoted the mitochondrial unfolded protein response. Our findings highlight 4E-BP1 as a therapeutic target in neurodegenerative disease and underscore the importance of the mitochondrial unfolded protein response in neuroprotection against various insults.
Copyright © 2020 the authors.

Entities:  

Keywords:  4E-BP1; Parkinson's disease; alpha-synuclein; mitochondrial unfolded protein response; neuroprotection; protein translation

Mesh:

Substances:

Year:  2020        PMID: 33046555      PMCID: PMC7643294          DOI: 10.1523/JNEUROSCI.0940-20.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.

Authors:  Taichi Hara; Kenji Nakamura; Makoto Matsui; Akitsugu Yamamoto; Yohko Nakahara; Rika Suzuki-Migishima; Minesuke Yokoyama; Kenji Mishima; Ichiro Saito; Hideyuki Okano; Noboru Mizushima
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

2.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 3.  Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.

Authors:  J Q Trojanowski; M Goedert; T Iwatsubo; V M Lee
Journal:  Cell Death Differ       Date:  1998-10       Impact factor: 15.828

4.  Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum.

Authors:  T Fujiwara; K Oda; S Yokota; A Takatsuki; Y Ikehara
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

5.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

6.  Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.

Authors:  Yuzuru Imai; Stephan Gehrke; Hua-Qin Wang; Ryosuke Takahashi; Kazuko Hasegawa; Etsuro Oota; Bingwei Lu
Journal:  EMBO J       Date:  2008-08-14       Impact factor: 11.598

7.  Autism-related deficits via dysregulated eIF4E-dependent translational control.

Authors:  Christos G Gkogkas; Arkady Khoutorsky; Israeli Ran; Emmanouil Rampakakis; Tatiana Nevarko; Daniel B Weatherill; Cristina Vasuta; Stephanie Yee; Morgan Truitt; Paul Dallaire; François Major; Paul Lasko; Davide Ruggero; Karim Nader; Jean-Claude Lacaille; Nahum Sonenberg
Journal:  Nature       Date:  2012-11-21       Impact factor: 49.962

Review 8.  Mammalian target of rapamycin (mTOR) pathways in neurological diseases.

Authors:  Michael Wong
Journal:  Biomed J       Date:  2013 Mar-Apr       Impact factor: 4.910

Review 9.  Toxic proteins in neurodegenerative disease.

Authors:  J Paul Taylor; John Hardy; Kenneth H Fischbeck
Journal:  Science       Date:  2002-06-14       Impact factor: 47.728

10.  Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation.

Authors:  Christian Münch; J Wade Harper
Journal:  Nature       Date:  2016-06-22       Impact factor: 49.962

View more
  3 in total

1.  Activation of mTORC1 and c-Jun by Prohibitin1 loss in Schwann cells may link mitochondrial dysfunction to demyelination.

Authors:  Gustavo Della-Flora Nunes; Emma R Wilson; Edward Hurley; Bin He; Bert W O'Malley; Yannick Poitelon; Lawrence Wrabetz; M Laura Feltri
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

Review 2.  The Unfolded Protein Responses in Health, Aging, and Neurodegeneration: Recent Advances and Future Considerations.

Authors:  Andrew P K Wodrich; Andrew W Scott; Arvind Kumar Shukla; Brent T Harris; Edward Giniger
Journal:  Front Mol Neurosci       Date:  2022-02-25       Impact factor: 5.639

Review 3.  Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; Diana Reche-López; Paula Cilleros-Holgado; Rocío Piñero-Pérez; José A Sánchez-Alcázar
Journal:  Biomedicines       Date:  2022-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.